EDGAR Filing Documents for 0001279569-10-000055

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-10-000055

Filing Date

2010-01-14

Accepted

2010-01-14 08:56:43

Documents

Period of Report

2009-11-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	lorus6k.htm	6-K	15205
2	NEWS RELEASE DATED JANUARY 14, 2010	ex991.htm	EX-99.1	94067
3	Q2 INTERIM FINANCIAL STATEMENTS	ex992.htm	EX-99.2	552568
4	Q2 MANAGEMENT DISCUSSION AND ANALYSIS	ex993.htm	EX-99.3	200753
5	CEO/CFO CERTIFICATES	ex994.htm	EX-99.4	33899
6	LORUS THERAPEUTICS INC. LOGO	lorus.jpg	GRAPHIC	11681
	Complete submission text file	0001279569-10-000055.txt		914373

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 10526450
SIC: 2836 Biological Products, (No Diagnostic Substances)